Spatially Segregated Electrochemical Sensor for Simultaneous Detection of Prostate-Specific Antigen and Sarcosine with Boosted Clinical Prediction of Early Prostate Cancer
- 27 October 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Sensors
Abstract
Accurate early screening for prostate cancer (PCa) is critical to clinical decision-making. Simultaneous detection of the independent biomarkers sarcosine (Sar) and prostate-specific antigen (PSA) can improve screening accuracy for PCa through cross-validation. However, co-immobilizing the two detection units on the sensor surface causes close intermingling, leading to mutual interference between PSA and Sar detection, which severely reduces detection sensitivity. To address this issue, we adopted a spatial segregation strategy that allows Sar and PSA to be detected inside the pores and on the external surface of the metal–organic framework (MOF) sensors, respectively. First of all, we screened various MOFs through density functional theory calculations and adsorption experiments and found that MOF-74(Ni) outperformed other MOFs in adsorbing Sar. The nanozyme riboflavin (Rf) encapsulated within MOF-74 pores enables intracavity detection of small Sar molecules by size-sieving and cascade reaction. Concurrently, the ferrocene-labeled peptides (Pep-Fc), which are specifically cleavable by PSA, were immobilized on the surface to detect the large PSA molecules excluded from the pores. Finally, the MOF-74/Rf@Pep-Fc electrochemical sensor was constructed for spatial segregation detection. A series of results from adsorption kinetics and anti-interference experiments confirmed that this design can effectively eliminate the mutual interference between Sar and PSA. The sensor demonstrates a limit of detection of 0.78 fg/mL for Sar and 0.065 fg/mL for PSA. Clinical validation in serum showed that the sensor achieved 100% PCa predictive accuracy for PSA > 20 ng/mL, and in the 4–20 ng/mL range, simultaneous detection raised accuracy from < 50% to > 85%, highlighting its clinical potential.Keywords
Funding Information
- Guangxi Medical University (DC2500001200)
- Guangxi Medical University (DC2500001220)
- Natural Science Foundation of Guangxi Zhuang Autonomous Region (2022JJB140197)
- Natural Science Foundation of Guangxi Zhuang Autonomous Region (2024JJA141067)
- Natural Science Foundation of Guangxi Zhuang Autonomous Region (2024JJB140509)
- Natural Science Foundation of Guangxi Zhuang Autonomous Region (2026GXNSFDA00640015)
- National Natural Science Foundation of China (22172039)
- National Natural Science Foundation of China (82060145)
- National Natural Science Foundation of China (82460596)
This publication has 46 references indexed in Scilit:
- Multilayered Sandwich Structure Sensor: Confinement‐Mediated H 2 O 2 Enrichment Strategy for Ultrasensitive and Long‐term Stable Prostate Cancer Biomarker DetectionSmall, 2025
- Achieving Highly Reversible Mn2+/MnO2 Conversion Reaction in Electrolytic Zn‐MnO2 Batteries via Electrochemical‐Chemical Process RegulationAngewandte Chemie International Edition, 2025
- A Photoelectrochemical Sensor for Glutathione Detection Based on a Target-triggered Etching StrategyJournal of Analysis and Testing, 2025
- Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoLOncology and Therapy, 2024
- Intelligent Screening of Prostate Cancer Individuals Using an Enzyme‐Assisted Multicolor Visualization PlatformAdvanced Science, 2024
- Electrochemical biosensors and power supplies for wearable health‐managing textile systemsInterdisciplinary Materials, 2024
- In Situ Synthesis of MOF‐74 Family for High Areal Energy Density of Aqueous Nickel–Zinc BatteriesAdvanced Materials, 2022
- Evaporation‐Induced rGO Coatings for Highly Sensitive and Non‐Invasive Diagnosis of Prostate Cancer in the PSA Gray ZoneAdvanced Materials, 2021
- An electrochemical sarcosine sensor based on biomimetic recognitionMicrochimica Acta, 2019
- The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐eraInternational Journal of Cancer, 2014